Subject: SeeThruEquity Updates Research on PSID with .20 Price Target

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
SeeThruEquity Updates Research on PSID with .20 Price Target
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (OTCQB: PSID)


Price: 0.0198

Change (%): + 0.0001 (0.50)

Volume: 206,998
PSID Chart

SeeThruEquity Issues Company Note on PositiveID (OTCQB: PSID)

NEW YORK, NY / ACCESSWIRE / January 25, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued a company note on PositiveID Corporation (OTCQB: PSID).

PositiveID Corporation, (OTCQB: PSID, “PositiveID”), is a life sciences company focused on developing and commercializing innovative products for biological testing, detection, and diagnostics. The company’s flagship product, the Firefly Dx,is a real-time, handheld molecular diagnostic system that utilizes polymerase chain reaction (PCR) chemistry, which is designed to be used in the field for biological threat and infectious disease detection without the use of bulky lab equipment. PositiveID has amassed an impressive list of customers and partners, including the U.S. Department of Homeland Security, NASA, and the U.S. Department of Defense, among others. PositiveID has continued to evolve since our last research update, with the completion of two complementary acquisitions that promise to augment its revenue base while expanding its capabilities to include complementary areas such as mobile labs and next generation thermometers. In our view, the acquisitions should help PositiveID benefit from scale and potentially obtain profitability as it advances development of the Firefly Dx, which is now expected to reach commercial stage during calendar year 2017E.

The report is available here: PSID January 2016 Update Note. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks